Think (Gram) negative!

Critical Care

Volumn 14, Issue 3, 2010, Pages

  Huttner, Benedikt ^a   Harbarth, Stephan ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CARBAPENEM; CEPHALOSPORIN; EXTENDED SPECTRUM BETA LACTAMASE; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; BIOSURVEILLANCE; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI INFECTION; GERMANY; GRAM NEGATIVE BACTERIUM; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE INFECTION; MULTIDRUG RESISTANCE; NONHUMAN; NOTE; PRIORITY JOURNAL; CLINICAL PRACTICE; DRUG EFFECT; GRAM NEGATIVE INFECTION; HEALTH SURVEY;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; GERMANY; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE UNITS; PHYSICIAN'S PRACTICE PATTERNS; POPULATION SURVEILLANCE;

EID: 79952113138     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9041     Document Type: Note

References (18)

1. Meyer E, Schwab F, Schoeren-Boersch B, Gastmeier P. Dramatic increase of third-generation cephalosporin resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001-2008. Crit Care 2010, 14:R113. 10.1186/cc9062, 20546564.
2. Jarlier V, Trystram D, Brun-Buisson C, Fournier S, Carbonne A, Marty L, Andremont A, Arlet G, Buu-Hoi A, Carlet J, Decré D, Gottot S, Gutmann L, Joly-Guillou ML, Legrand P, Nicolas-Chanoine MH, Soussy CJ, Wolf M, Lucet JC, Aggoune M, Brücker G, Régnier B, . Collégiale de Bactériologie-Virologie-Hygiène des Hôpitaux Universitaires de l'Ile de France Curbing methicillin resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program. Arch Intern Med 2010, 170:552-559. 10.1001/archinternmed.2010.32, 20308642, Collégiale de Bactériologie-Virologie-Hygiène des Hôpitaux Universitaires de l'Ile de France.
3. Liebowitz LD. MRSA burden and interventions. Int J Antimicrob Agents 2009, 34(Suppl 3):S11-13. 10.1016/S0924-8579(09)70551-5, 19596108.
4. Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill 2008, 13(47):pii:19044.
5. Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Ruíz M, Peña C, Almela M, Almirante B, Grill F, Colomina J, Giménez M, Oliver A, Horcajada JP, Navarro G, Coloma A, Pascual A, . Spanish Network for Research in Infectious Diseases (REIPI) Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli risk factors and prognosis. Clin Infect Dis 2010, 50:40-48. 19995215, 10.1086/649537, Spanish Network for Research in Infectious Diseases (REIPI).
6. Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase producing K. pneumoniae. Infect Control Hosp Epidemiol 2009, 30:1180-1185. 10.1086/648451, 19860564.
7. Harbarth S, Harris AD, Carmeli Y, Samore MH. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram negative bacilli. Clin Infect Dis 2001, 33:1462-1468. 10.1086/322677, 11588690.
8. Harbarth S, Pittet D. Multiresistance of gram-negative bacteria in intensive care units: bad news from without. Crit Care Med 1999, 27:1037-1038. 10.1097/00003246-199906000-00003, 10397191.
9. Hammerum AM, Heuer OE. Human health hazards from antimicrobial resistant Escherichia coli of animal origin. Clin Infect Dis 2009, 48:916-921. 10.1086/597292, 19231979.
10. Jakobsen L, Kurbasic A, Skjøt-Rasmussen L, Ejrnaes K, Porsbo LJ, Pedersen K, Jensen LB, Emborg HD, Agersø Y, Olsen KE, Aarestrup FM, Frimodt-Møller N, Hammerum AM. Escherichia coli isolates from broiler chicken meat, broiler chickens, pork, and pigs share phylogroups and antimicrobial resistance with community-dwelling humans and patients with urinary tract infection. Foodborne Pathog Dis 2010, 7:537-547. 10.1089/fpd.2009.0409, 20039794.
11. Valverde A, Grill F, Coque TM, Pintado V, Baquero F, Canton R, Cobo J. High rate of intestinal colonization with extended-spectrum-beta-lactamase producing organisms in house hold contacts of infected community patients. J Clin Microbiol 2008, 46:2796-2799. 2519510, 18562591, 10.1128/JCM.01008-08.
12. Muller A, Coenen S, Monnet DL, Goossens H. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe, 1998-2005. Euro Surveill 2007, 12:E071011-071011.
13. Hanberger H, Arman D, Gill H, Jindrák V, Kalenic S, Kurcz A, Licker M, Naaber P, Scicluna EA, Vanis V, Walther SM. Surveillance of microbial resistance in European Intensive Care Units: a first report from the Care-ICU programme for improved infection control. Intensive Care Med 2009, 35:91-100. 10.1007/s00134-008-1237-y, 18670757.
14. Kern WV, Steib-Bauert M, Amann S, Fellhauer M, de With K. Hospital antibiotic management in Germany - results of the ABS maturity survey of the ABS International group. Wien Klin Wochenschr 2008, 120:294-298. 10.1007/s00508-008-0971-z, 18545954.
15. NRZ für gram-negative Krankenhauserreger. , http://memiserf.medmikro.ruhr-uni-bochum.de/nrz/
16. Wendt C, Schutt S, Dalpke AH, Konrad M, Mieth M, Trierweiler-Hauke B, Weigand MA, Zimmermann S, Biehler K, Jonas D. First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in Germany. Eur J Clin Microbiol Infect Dis 2010, 29:563-570. 10.1007/s10096-010-0896-0, 20213255.
17. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009, 9:228-236. 10.1016/S1473-3099(09)70054-4, 19324295.
18. Carmeli Y, Akova M, Cornaglia G, Daikos GL, Garau J, Harbarth S, Rossolini GM, Souli M, Giamarellou H. Controlling the spread of carbapenemase producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect 16:102-111. 10.1111/j.1469-0691.2009.03115.x, 20085604.